As Trump 2.0 targets federal research, a new study shows the stakes
The biopharma industry tipped the scales on cancer research years ago. Where the federal government once played a major role in determining what was studied in clinical trials, industry players took a commanding lead. And ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.